Literature DB >> 11804183

Osteopontin(OPN)-induced increase in human mammary epithelial cell invasiveness is urokinase (uPA)-dependent.

A B Tuck1, C Hota, A F Chambers.   

Abstract

We have recently shown that either exogenous or endogenous, transfected OPN induces both uPA expression and increased invasiveness of 21 PT (non-tumorigenic) and 21 NT (tumorigenic) human mammary epithelial cells. Here we asked whether uPA contributes functionally to the increased invasiveness of these cells. The most invasive OPN-transfected cells were assessed for migration through Matrigel in transwell assays, in the presence or absence of various blocking antibodies and uPA inhibitors. Antibodies to both uPA and uPA receptor (uPAR) were shown to significantly inhibit cell invasion, as did the uPA inhibitors (plasminogen activator inhibitor-1 [PAI-1], p-aminobenzamidine [PABN], aprotinin, and amiloride). Both anti-uPA and anti-uPAR antibodies inhibited invasion to a level comparable to that of the control vector transfected cells. In contrast, non-specific IgG showed no antiinvasive effect. Cell migration experiments performed with the parental cell lines in the presence or absence of anti-uPA or anti-uPAR antibodies showed that uPA is also required for migratory responsiveness to exogenous OPN. These data thus provide direct evidence that OPN-induced invasion and migration of these cells requires uPA.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11804183     DOI: 10.1023/a:1013095329825

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  29 in total

1.  Inhibition of osteopontin reduces liver metastasis of human pancreatic cancer xenografts injected into the spleen in a mouse model.

Authors:  Keisuke Ohno; Hidefumi Nishimori; Takahiro Yasoshima; Kenjiro Kamiguchi; Fumitake Hata; Rika Fukui; Koichi Okuya; Yasutoshi Kimura; Ryuichi Denno; Shigeyuki Kon; Toshimitsu Uede; Noriyuki Sato; Koichi Hirata
Journal:  Surg Today       Date:  2010-03-26       Impact factor: 2.549

2.  Role of the integrin-binding protein osteopontin in lymphatic metastasis of breast cancer.

Authors:  Alison L Allan; Rosamma George; Sharon A Vantyghem; Mark W Lee; Nicole C Hodgson; C Jay Engel; Ron L Holliday; David P Girvan; Leslie A Scott; Carl O Postenka; Waleed Al-Katib; Larry W Stitt; Toshimitsu Uede; Ann F Chambers; Alan B Tuck
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

3.  Effect of a 12-month exercise intervention on serum biomarkers of angiogenesis in postmenopausal women: a randomized controlled trial.

Authors:  Catherine Duggan; Liren Xiao; Ching-Yun Wang; Anne McTiernan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-02-05       Impact factor: 4.254

Review 4.  Osteopontin: an effector and an effect of tumor metastasis.

Authors:  L A Shevde; S Das; D W Clark; R S Samant
Journal:  Curr Mol Med       Date:  2010-02       Impact factor: 2.222

5.  Vaccine-mediated immunotherapy directed against a transcription factor driving the metastatic process.

Authors:  Andressa Ardiani; Sofia R Gameiro; Claudia Palena; Duane H Hamilton; Anna Kwilas; Thomas H King; Jeffrey Schlom; James W Hodge
Journal:  Cancer Res       Date:  2014-02-11       Impact factor: 12.701

6.  RNA aptamer blockade of osteopontin inhibits growth and metastasis of MDA-MB231 breast cancer cells.

Authors:  Zhiyong Mi; Hongtao Guo; M Benjamin Russell; Yingmiao Liu; Bruce A Sullenger; Paul C Kuo
Journal:  Mol Ther       Date:  2008-11-04       Impact factor: 11.454

7.  Role of inflammation in túbulo-interstitial damage associated to obstructive nephropathy.

Authors:  María T Grande; Fernando Pérez-Barriocanal; José M López-Novoa
Journal:  J Inflamm (Lond)       Date:  2010-04-22       Impact factor: 4.981

8.  Effects of osteopontin inhibition on radiosensitivity of MDA-MB-231 breast cancer cells.

Authors:  Antje Hahnel; Henri Wichmann; Matthias Kappler; Matthias Kotzsch; Dirk Vordermark; Helge Taubert; Matthias Bache
Journal:  Radiat Oncol       Date:  2010-09-17       Impact factor: 3.481

9.  Induction of osteopontin expression by nicotine and cigarette smoke in the pancreas and pancreatic ductal adenocarcinoma cells.

Authors:  Galina Chipitsyna; Qiaoke Gong; Rathai Anandanadesan; Amer Alnajar; Surinder K Batra; Uwe A Wittel; Diane M Cullen; Mohammed P Akhter; David T Denhardt; Charles J Yeo; Hwyda A Arafat
Journal:  Int J Cancer       Date:  2009-07-15       Impact factor: 7.396

10.  Osteopontin is overexpressed in colorectal carcinoma and is correlated with P53 by immunohistochemistry.

Authors:  Jing Li; Guang-Zhi Yang; Zi-Man Zhu; Zhi-Yong Zhou; Lin Li
Journal:  Exp Ther Med       Date:  2012-01-30       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.